IPHA
Innate Pharma
IPHA
IPHA
9 hedge funds and large institutions have $1.13M invested in Innate Pharma in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$311K | |
| 2 | -$27.8K | |
| 3 | -$11K | |
| 4 |
Morgan Stanley
New York
|
-$1.84K |
| 5 |
Citigroup
New York
|
-$201 |